可溶性尿激酶纤溶酶原激活物受体可预测抗逆转录病毒治疗病毒抑制期间的非艾滋病事件
该研究基于纵向观察试验,纳入141例病例和310例匹配对照,所有患者均在ART治疗1年及之后保持病毒抑制。研究发现,suPAR水平在ART前、ART1年后及事件前均与non-AIDS事件风险独立相关(每1 IQR的OR分别为1.7、2.0、2.1),而BDG和LBP仅在ART1年后和事件前与风险相关。
要点
- suPAR在ART前、ART1年后及事件前均独立预测non-AIDS事件。
- BDG和LBP仅在ART1年后和事件前与non-AIDS事件风险相关。
- 其他生物标志物未显示与non-AIDS事件的关联。
核心结论
- suPAR水平升高在每个测量时间点均强烈、一致且独立地预测non-AIDS事件。
研究设计与样本
- 纵向观察试验中选取141例病例和310例匹配对照,所有患者在ART治疗1年及之后保持病毒抑制。
主要发现
- suPAR每1 IQR的OR在ART前为1.7,ART1年后为2.0,事件前为2.1。
- BDG和LBP在ART1年后和事件前与non-AIDS事件风险升高相关,但基线时无关联。
- 其他生物标志物未观察到与non-AIDS事件的关联。
临床怎么用
- suPAR或可作为预测HIV病毒抑制患者non-AIDS事件风险的生物标志物。
- 针对suPAR通路的干预措施值得研究,以探索其在non-AIDS结局发病机制中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite effective antiretroviral therapy (ART), human immunodeficiency virus (HIV) infection remains associated with higher morbidity and mortality, driven, in part, by increased inflammation. Our objective was to identify associations between levels of plasma biomarkers of chronic inflammation, microbial translocation, and monocyte activation, with occurrence of non-AIDS events. METHODS: Participants (141 cases, 310 matched controls) were selected from a longitudinal observational trial; all were virally suppressed on ART at year 1 and thereafter. Soluble urokinase plasminogen activator receptor (suPAR), lipopolysaccharide binding protein (LBP), beta-D-glucan (BDG), intestinal fatty-acid binding protein, oxidized low-density lipoproteins, and soluble CD163 were measured pre-ART, after 1-year of ART, and pre-event. At each time point, conditional logistic regression analysis assessed associations of the biomarkers with events and adjusted for relevant covariates to calculate odds ratios (ORs) according to 1 interquartile range (IQR) difference. RESULTS: At all time points, higher levels of suPAR were associated with increased risk of non-AIDS events (OR per 1 IQR was 1.7 before ART-initiation, OR per 1 IQR was 2.0 after 1 year of suppressive ART, and OR 2.1 pre-event). Higher levels of BDG and LBP at year 1 and pre-event (but not at baseline) were associated with increased risk of non-AIDS events. No associations were observed for other biomarkers. CONCLUSIONS: Elevated levels of suPAR were strongly, consistently, and independently predictive of non-AIDS events at every measured time point. Interventions that target the suPAR pathway should be investigated to explore its role in the pathogenesis of non-AIDS-related outcomes in HIV infection.
引用
- Hoenigl M, Moser CB, Funderburg N, et al. Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression. Clin Infect Dis. 2019. PMID: 30418519. doi:10.1093/cid/ciy966
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。